EssilorLuxottica's Outstanding Q3 Performance
EssilorLuxottica has set a remarkable milestone in its journey, recording a stunning 11.7% increase in revenue during the third quarter of 2025. This marks the best quarterly performance in the history of the Group, showcasing not just growth but a strong foothold in the ever-evolving eyewear and vision care market.
Key Financial Highlights
The Group's consolidated revenue reached an impressive Euro 6,867 million for Q3 2025, reflecting a substantial rise compared to the previous year. The growth can be attributed significantly to the consistent performance across various markets, particularly in wearables, where innovation is rapidly advancing.
Revenue Growth Across Categories
In addition to the overall revenue increase, wearables have notably contributed to this growth. With advancements in product innovation, EssilorLuxottica is expanding its portfolio, offering consumers cutting-edge technology and enhanced user experiences. Furthermore, segments like vision care and sunglasses also saw a 5% rise, indicating strong demand and consumer confidence.
Regional Successes
The impressive growth was evident worldwide, with North America and EMEA (Europe, the Middle East, and Africa) experiencing double-digit increases in both retail and direct-to-consumer channels. This reflects how the Group's strategic initiatives align with market demands, resulting in significant traction in various regions.
Innovations and Acquisitions Driving Growth
EssilorLuxottica's dedication to innovation is exemplified by the launch of the latest AI glasses collections, including Ray-Ban Meta and Oakley Meta. This cutting-edge technology aims to enhance human capabilities and redefine the wearable market. As part of its ongoing commitment, the company has also made strides in the medical technology field, especially with Stellest lenses, which assist in myopia management.
Expanding the Vision-Health Ecosystem
The recent acquisitions of Optegra and RetinAI further illustrate EssilorLuxottica's intention to form a comprehensive vision-health ecosystem. With these strategic moves, the Group is poised to integrate AI in preventive health care, ensuring that they lead the way in offering innovative solutions that empower individuals globally.
Leaders’ Perspective
Francesco Milleri, Chairman and CEO, alongside Deputy CEO Paul du Saillant, expressed pride in these results, emphasizing how the Group's vision and management capabilities foster exceptional outcomes. They highlighted that the continuous improvements in EMEA and North America are proof of their strategic direction and commitment.
Looking Ahead
As the Company approaches the final quarter of the year, they carry forward this momentum with aspirations for continuous transformation. The synergy of innovation, scientific advancements, and human potential forms the backbone of EssilorLuxottica's future direction, aiming to create enduring impacts in the eyewear industry.
Frequently Asked Questions
What are the recent revenue findings for EssilorLuxottica?
EssilorLuxottica reported an 11.7% increase in revenue for Q3 2025, reaching Euro 6,867 million.
How has innovation influenced EssilorLuxottica's growth?
The introduction of advanced wearables, including AI glasses, and the integration of medical technology have been critical in driving the Group's growth.
What markets are driving EssilorLuxottica's performance?
Significant gains have been observed in North America and EMEA, where double-digit growth has been noted in both retail and direct channels.
What strategic acquisitions has EssilorLuxottica made recently?
The acquisition of Optegra and RetinAI enhances the Group's capabilities in health and vision care, focusing on the integration of AI in their services.
What are the future plans of EssilorLuxottica?
The Group aims to maintain its momentum into the fourth quarter, focusing on innovation and transforming the vision health ecosystem.
